MedTrace Logo

Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer

NCT05460416 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2025-02-18

No results posted yet for this study

Summary

Title: A prospective multicentric interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of pre-eclampsia in pregnant women who underwent frozen embryo transfer

Conditions

  • Embryo Transfer
  • Hypertension, Pregnancy Induced

Interventions

DRUG

Acetylsalicylic acid

160mg once a day

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Liege

    lead OTHER

Principal Investigators

  • Laurie Henry · Centre Hospitalier Régional de la Citadelle

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05460416 on ClinicalTrials.gov